The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWeir Group Regulatory News (WEIR)

Share Price Information for Weir Group (WEIR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,112.00
Bid: 2,112.00
Ask: 2,114.00
Change: -2.00 (-0.09%)
Spread: 2.00 (0.095%)
Open: 2,114.00
High: 2,122.00
Low: 2,108.00
Prev. Close: 2,114.00
WEIR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

13 Jul 2023 11:59

RNS Number : 9601F
Mizuho International plc
13 July 2023
 

13/07/2023

 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

WEIR Group Plc/The

 

Stabilisation Notice

Mizuho International plc (contact: Syndicate Desk - Maximilian Wegener; telephone: +4969427293155) hereby gives notice that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

The securities:

Issuer:

WEIR Group Plc/The

Guarantor (if any):

Aggregate nominal amount:

GBP 300m WEIRLN 6 ⅞ 06/14/28

Description:

Senior, Unsecured, RegS Bearer Notes due in 2028

Offer price:

99.753

Other offer terms:

Stabilisation: Not carried out

Stabilising Manager(s):

Mizuho International plc (Stabilisation Coordinator)

Citigroup Global Markets Ltd

JP Morgan SE

HSBC

 

Stabilisation period expected to start on:

7th of June 2023

Stabilisation period expected to end no later than:

13th July 2023 (30 days after the proposed issue date of the securities)

Maximum size of over-allotment facility:

[5% of the aggregate nominal amount stated above.]

 

In connection with the offer of the above securities, the Stabilising Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is only directed at, and the securities are only available to, persons having professional experience in matters related to investments and high net worth companies and other persons to whom article 49(2) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2001 applies and should not be acted on by others.

To the extent that the offer of the securities is made in any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the date of publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or, where appropriate, published in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), the offer is only addressed to qualified investors in that Member State within the meaning of the Prospectus Directive or has been or will be made otherwise in circumstances that do not require the Issuer to publish a prospectus pursuant to the Prospectus Directive.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

END

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STARJMMTMTABBJJ
Date   Source Headline
1st Mar 20224:27 pmRNSVoting Rights and Share Capital
3rd Feb 20224:38 pmRNSDirector Declaration
31st Jan 20223:03 pmRNSTotal Voting Rights
12th Jan 202211:00 amRNSHolding(s) in Company
6th Jan 20222:44 pmRNSTotal Voting Rights
6th Jan 20227:00 amRNSWeir commits to science-based emission reductions
6th Dec 20211:29 pmRNSDirector Declaration
1st Dec 20217:00 amRNSWeir completes purchase of Motion Metrics
30th Nov 20214:06 pmRNSTotal Voting Rights
9th Nov 20214:43 pmRNSDirector/PDMR Shareholding
5th Nov 20219:15 amRNSWeir to acquire Motion Metrics
1st Nov 202110:46 amRNSTotal Voting Rights
7th Oct 20215:34 pmRNSQ3 trading update and cybersecurity incident
1st Oct 202111:54 amRNSBlock listing Interim Review
30th Sep 20214:20 pmRNSTotal Voting Rights
17th Sep 20212:35 pmRNSDirector/PDMR Shareholding
3rd Sep 20217:00 amRNSChair-Designate Appointed
31st Aug 20214:15 pmRNSTotal Voting Rights
23rd Aug 202112:15 pmRNSDirector/PDMR Shareholding
2nd Aug 202111:38 amRNSTotal Voting Rights
29th Jul 20217:00 amRNSHalf-year Report
7th Jul 20215:30 pmRNSDirector Declaration
30th Jun 20214:01 pmRNSTotal Voting Rights
21st Jun 20219:29 amRNSHolding(s) in Company
1st Jun 202110:39 amRNSTotal Voting Rights
27th May 20212:49 pmRNSDirector/PDMR Shareholding
19th May 20214:18 pmRNSHolding(s) in Company
12th May 20214:31 pmRNSHolding(s) in Company
10th May 20213:44 pmRNSHolding(s) in Company
7th May 20217:00 amRNSPricing of Sustainability-Linked Notes
6th May 202110:18 amRNSDirector/PDMR Shareholding
5th May 20211:52 pmRNSHolding(s) in Company
4th May 202111:38 amRNSDirector/PDMR Shareholding
4th May 202111:34 amRNSDirector/PDMR Shareholding
4th May 202111:32 amRNSDirector/PDMR Shareholding
4th May 202111:27 amRNSDirector/PDMR Shareholding
4th May 202111:24 amRNSDirector/PDMR Shareholding
4th May 202111:23 amRNSDirector/PDMR Shareholding
4th May 202111:18 amRNSDirector/PDMR Shareholding
4th May 202111:14 amRNSDirector/PDMR Shareholding
30th Apr 20212:30 pmRNSDirector/PDMR Shareholding
30th Apr 202112:24 pmRNSTotal Voting Rights
29th Apr 20215:18 pmRNSBoard Committee Changes
29th Apr 20214:32 pmRNSResult of AGM
29th Apr 20217:00 amRNSQ1 Trading Update
27th Apr 20213:06 pmRNSHolding(s) in Company
19th Apr 20214:21 pmRNSHolding(s) in Company
13th Apr 20211:07 pmRNSDirector/PDMR Shareholding
13th Apr 202112:59 pmRNSDirector/PDMR Shareholding
13th Apr 202112:55 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.